Assif Stoffman
Executive Chairman
Your CSV is on the way
We’ve sent your CSV file to email@email.com
Claimed by
owner Add to list
EndoCross
Former names:
Medical Devices for Cardiovascular Treatment
Stealth Mode
Oct 2017
EndoCross
EndoCross Overview
EndoCross develops and markets solutions to treat challenging lesions, including chronic total occlusions (CTOs). Its first product, the ENABLER-P Catheter System, is CE marked and designed for use in the peripheral vasculature, including above-the-knee and below-the-knee vessels. The company is also introducing the ENABLER-C Catheter System for use in coronary environments.
The ENABLER technology can advance a guidewire in challenging environments, including crossing long and severely calcified CTOs. Using traditional balloon technologies, EndoCross has developed a balloon designed to provide guidewire support, centralization, and controlled advancement.
The full ENABLER Catheter System comprises the ENABLER-P Catheter, the ENABLER Pressure Control Unit, a syringe set, and a sterile cover.
The ENABLER technology can advance a guidewire in challenging environments, including crossing long and severely calcified CTOs. Using traditional balloon technologies, EndoCross has developed a balloon designed to provide guidewire support, centralization, and controlled advancement.
The full ENABLER Catheter System comprises the ENABLER-P Catheter, the ENABLER Pressure Control Unit, a syringe set, and a sterile cover.
Cumulative Funding Raised Over Time ($)
Employees Over Time
EndoCross Climate Tech relevance
null
Companies you might be interested in
Driven by Finder AI
Primary sector
Total funding
Funding stage
Number of employees
Founded
Related Content
Lists. Maps. Reports
Team Members
AS
EH
YE
MB
Contact Team
Affiliated Organizations
(null)Web & social links
Locations
Israel
Yokne'am Illit, Israel
Offices Abroad
Photos & videos
(1)No Data, yet.
Sorry, no content found under this section.
EndoCross Business
Sector
Primary:
Health Tech & Life Sciences
Target Customer
Core Technology
Use Cases
(0)Tech Community Involvement
(0)EndoCross Financials
Cumulative Funding Raised Over Time ($)
No Data, yet.
Sorry, no content found under this section.
Public Offerings & Exits
Private Equity Funding
Undisclosed Round
$2.5M
Nov 2008
2
Investors
$2.5M
Non-Equity Funding
Mergers and Acquisitions
EndoCross Lifecycle
Cumulative Funding Raised Over Time ($)
Timeline
Employees Over Time
News Over Time
No Data, yet.
Sorry, no content found under this section.
Closing Event
Oct 2017
Undisclosed Round
$2.5M
Nov 2008
2
Investors
$2.5M
EndoCross News
News Over Time
No Data, yet.
Sorry, no content found under this section.
News Articles
Sep 23, 2014
www.medgadget.com
EndoCross ENABLER-C System for Crossing Total Coronary Occlusions Approved in Europe
#Customers
Related Content
EndoCross Team
No Data, yet.
Sorry, no content found under this section.
Employees Over Time
Companies you might be interested in
Driven by Finder AI
EndoCross Internal
Create note
Notes
(undefined)
Filter notes
Content Writer
undefined
BI Verification
undefined
Phone Number
undefined
Israel Register ID
undefined
Confidence Score
undefined
Missing Fields
undefined
Profile Creator
undefined
Profile Update
undefined
undefined
Access Comprehensive Financial Analytics
Create a free account to:
- Explore detailed financial analytics.
- Track company growth and size.
- Connect with company team members.
I already have access,
I already have access,